Frontlight ResearchEarly access
Triple-negative breast cancer trials in Italy
31 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleOrganoids From Breast Cancer Patients Treated With Neoadjuvant Therapy
- Where
- Pavia
- Age
- 18 years and over
- People
- 240
- Run by
- Istituti Clinici Scientifici Maugeri SpA
See details and how to joinNCT07260188 - No phaseNot yet taking people in ItalyNeutrophil Biomarker Test for Predicting Clinical Benefit From Immunotherapy Based on Flow Cytometry Analysis
- Where
- Milan
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- OncoHost Ltd.
See details and how to joinNCT07246759 - Phase 2Taking peopleOmission of Local Therapies in Women Patients With HER2-positive or Triple-negative Breast Cancer
- Where
- Milan
- Age
- 18 years and over
- People
- 152
- Run by
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
See details and how to joinNCT06938724 - Phase 2Active, not recruitingRestoring Sensitivity To Immunotherapy In Advanced Triple Negative Breast Cancer Exploiting Ceralasertib Priming Followed By Combined Durvalumab/Nab-Paclitaxel
- Where
- Bergamo, Milan, Napoli, Novara, Padova, Reggio Emilia
- Age
- 18 years and over
- People
- 37
- Run by
- IFOM ETS - The AIRC Institute of Molecular Oncology
See details and how to joinNCT05582538 · EU 2024-513721-23-00 - Phase 2Taking peopleRepurposing statins as adjuvants for cancer patients receiving therapy with immune checkpoint inhibitors: the STARK trial
- Where
- Bergamo, Milan, Orbassano, Padova
- Age
- 18 years and over
- People
- 90
- Run by
- Universita Degli Studi Di Padova
See details and how to join2024-518500-47-00 - No phaseTaking peopleVabb After Neoadjuvant Therapy to Avoid Surgery-pCR to Avoid Breast Surgery
- Where
- Candiolo, Milan
- Age
- 18 years and over
- People
- 77
- Run by
- European Institute of Oncology
See details and how to joinNCT06281210